CATALOGO DEI PRODOTTI DELLA RICERCA

UGEL, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.257
EU - Europa 5.681
AS - Asia 3.530
SA - Sud America 514
Continente sconosciuto - Info sul continente non disponibili 238
AF - Africa 132
OC - Oceania 23
Totale 16.375
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.003
RU - Federazione Russa 2.103
SG - Singapore 1.320
IT - Italia 1.073
CN - Cina 936
GB - Regno Unito 899
BR - Brasile 396
DE - Germania 376
VN - Vietnam 368
HK - Hong Kong 352
FI - Finlandia 229
FR - Francia 215
IE - Irlanda 208
SE - Svezia 204
BD - Bangladesh 117
CA - Canada 105
NL - Olanda 104
KR - Corea 103
IN - India 69
ID - Indonesia 54
UA - Ucraina 51
MX - Messico 44
TR - Turchia 40
JP - Giappone 39
AR - Argentina 38
AT - Austria 38
ZA - Sudafrica 33
ES - Italia 32
BE - Belgio 31
PL - Polonia 28
NG - Nigeria 24
CR - Costa Rica 21
IQ - Iraq 21
AU - Australia 20
CO - Colombia 20
JM - Giamaica 19
TG - Togo 19
CZ - Repubblica Ceca 17
IL - Israele 16
BJ - Benin 15
EC - Ecuador 15
SA - Arabia Saudita 15
PK - Pakistan 14
VE - Venezuela 14
TT - Trinidad e Tobago 11
GT - Guatemala 10
MA - Marocco 10
PH - Filippine 10
PY - Paraguay 10
SV - El Salvador 10
CH - Svizzera 9
CW - ???statistics.table.value.countryCode.CW??? 9
LT - Lituania 9
NI - Nicaragua 8
PT - Portogallo 8
TN - Tunisia 8
CL - Cile 7
PE - Perù 7
EG - Egitto 6
HN - Honduras 6
KE - Kenya 6
PR - Porto Rico 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
MY - Malesia 5
PS - Palestinian Territory 5
CY - Cipro 4
DO - Repubblica Dominicana 4
HR - Croazia 4
OM - Oman 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
GP - Guadalupe 3
HU - Ungheria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
SC - Seychelles 3
TW - Taiwan 3
BG - Bulgaria 2
EU - Europa 2
GR - Grecia 2
GY - Guiana 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
Totale 16.124
Salva come PNG Salva come JPEG
Città #
Ashburn 997
Moscow 763
Southend 724
Singapore 656
San Jose 642
Verona 503
Dallas 434
Chandler 408
Hong Kong 338
Council Bluffs 235
New York 209
Munich 207
Beijing 200
Dublin 199
Jacksonville 188
Woodbridge 159
The Dalles 156
Ann Arbor 141
Los Angeles 137
Helsinki 107
Houston 104
Ho Chi Minh City 90
Santa Clara 89
Redmond 84
Milan 65
Hanoi 64
Princeton 62
Lawrence 61
Wilmington 59
Jinan 58
Orem 51
Shenyang 51
Buffalo 50
São Paulo 43
London 42
Nanjing 42
Jakarta 41
Redondo Beach 40
Turku 36
Atlanta 35
Chicago 34
Denver 34
Dong Ket 34
Tokyo 34
Amsterdam 32
Brooklyn 30
Brussels 30
Columbus 30
Frankfurt am Main 30
Montreal 30
Phoenix 29
Washington 29
Lappeenranta 28
Rome 28
Tianjin 28
Johannesburg 26
Zhengzhou 25
Abuja 23
Chennai 22
Hebei 22
Mexico City 22
Warsaw 22
Nanchang 21
Vienna 21
Ningbo 20
Haiphong 19
Hangzhou 19
Lomé 19
Stockholm 19
Toronto 19
Haikou 18
Guangzhou 17
Manchester 17
Nuremberg 17
Redwood City 17
San José 17
Sindelfingen 17
McKinney 16
Changsha 15
Cotonou 15
Paris 15
Seattle 15
Seoul 15
Boston 14
Da Nang 14
Jiaxing 14
Poplar 14
San Francisco 14
Boydton 12
St Louis 12
Sydney 12
Ankara 11
Boardman 11
Bologna 11
Las Vegas 11
Madrid 11
Norwalk 11
Padova 11
Rio de Janeiro 11
Taiyuan 11
Totale 9.765
Salva come PNG Salva come JPEG
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 404
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 334
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 320
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 319
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 303
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 300
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 279
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 278
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 268
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 261
Deciphering the state of immune silence in fatal COVID-19 patients 256
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 250
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 248
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 238
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 232
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 231
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 223
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 222
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 216
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 215
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 212
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 211
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 205
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 204
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 204
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 190
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 189
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 188
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 187
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 187
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 182
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 180
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 179
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 177
Local ablation disrupts immune evasion in pancreatic cancer 175
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 173
The Endless Saga of Monocyte Diversity 173
Anti-telomerase T cells adoptive transfer 173
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 173
Circulating IgG4+ Plasmablast Count as a Diagnostic Tool in Autoimmune Pancreatitis 172
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 171
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 169
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 167
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 167
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis 166
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 166
The Engagement Between MDSCs and Metastases: Partners in Crime 162
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies 159
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 157
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature 151
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 151
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development 151
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 149
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 148
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells 146
Role of arginine metabolism in immunity and immunopathology. 145
Therapeutic targeting of myeloid-derived suppressor cells. 144
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 143
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 142
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 142
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 141
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 141
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines 141
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 139
T-cell tracking using Cerenkov and radioluminescence imaging 139
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 138
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 138
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. 138
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 136
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 133
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 132
Immune-guided therapy of COVID-19. 130
Phenotypical Characterization and Isolation of Tumor-Derived Mouse Myeloid-Derived Suppressor Cells 129
Moonlighting Proteins Are Important Players in Cancer Immunology 128
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 127
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade 127
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO. 126
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 122
Monocytes in the Tumor Microenvironment 119
Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound 118
Tumor-Induced Myeloid-Derived Suppressor Cells 116
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy 115
The dark side of tumor-associated endothelial cells 114
GateMeClass: Gate Mining and Classification of cytometry data 112
HER2 Aberrations in NSCLC: So Close Yet So Far 109
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells 104
B-CELL RECEPTOR SIGNALING ACTIVITY IDENTIFIES PATIENTS WITH MANTLE CELL LYMPHOMA AT HIGHER RISK OF PROGRESSION 103
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 102
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 98
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines 96
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 81
Pre-diagnostic prognostic value of leukocytes count and neutrophil-to-lymphocyte ratio in patients who develop colorectal cancer 79
A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2- ORCHESTRA Project 71
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial 53
Corneal regenerative contribution of endogenous and grafted limbal-corneal cells in a mouse model of simple limbal-corneal epithelial transplantation 46
c-FLIP as a master regulator of immune homeostasis and disease mechanisms 34
Design, Synthesis, and Structural Evolution of Pseudo-Natural Product IDO1 Inhibitors and Degraders 21
Timing Matters: Effectiveness of Compressive Garments on Recovery in Trail Runners 21
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to Kras G12D Inhibition in Pancreatic Cancer 20
Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy 11
Totale 16.375
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.332
article - articoli 51.931
book - libri 0
conference - conferenze 1.884
curatela - curatele 0
other - altro 1.935
patent - brevetti 0
selected - selezionate 0
volume - volumi 582
Totale 112.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022305 0 0 0 0 18 12 17 38 49 17 41 113
2022/20231.268 72 165 105 221 102 310 23 71 130 8 38 23
2023/2024921 34 51 63 89 121 188 66 65 15 70 131 28
2024/20252.651 118 108 139 393 100 118 255 208 375 135 255 447
2025/20267.163 440 358 443 1.131 1.849 428 699 379 547 478 234 177
2026/20271.440 122 215 320 761 22 0 0 0 0 0 0 0
Totale 16.375